Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.370 AlteredExpression disease BEFREE Results showed miR-34a-5p expression in HCC tissues was significantly lower than in non HCC liver tissues (P < 0.05), but MCM2 expression in HCC tissues was markedly higher than in non HCC liver tissues (P < 0.05). 31034943 2019
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.370 Biomarker disease BEFREE We also observed that the expression of the MCM2-7 genes was increased in tumor tissue, and diagnostic receiver operating characteristic analysis of MCM2-7 indicated that these genes could serve as sensitive diagnostic markers in HCC. 30026832 2018
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.370 Biomarker disease BEFREE Proteomic Analysis and NIR-II Imaging of MCM2 Protein in Hepatocellular Carcinoma. 29750532 2018
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.370 Biomarker disease CTD_human Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling. 28284560 2017
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.370 Biomarker disease BEFREE In conclusion, these findings suggest that lnc-FTX may act as a tumor suppressor in HCC through physically binding miR-374a and MCM2. 27065331 2016
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.370 AlteredExpression disease BEFREE Overexpression of MCM2 protein related to poor-differentiation in HCC was validated using tissue microarray-based immunohistochemistry containing 96 HCCs. 20515756 2010
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.370 Biomarker disease BEFREE This study also shows that MCM2 and CCNB1 could be promising prognostic and therapeutic targets for HCC. 20515845 2010
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.370 Biomarker disease BEFREE The combination of MCM2, geminin and Ki67 could represent a valuable tool in the understanding of HCC progression in cirrhosis. 16629645 2006
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.370 Biomarker disease LHGDN The combination of MCM2, geminin and Ki67 could represent a valuable tool in the understanding of HCC progression in cirrhosis. 16629645 2006